Vertex Pharmaceuticals Inc has gained US approval for the first new type of painkiller in more than two decades, paving the way for a safer alternative to addictive opioids that have been linked to hundreds of thousands of deaths.
Vertex’s pill, called Journavx, received US Food and Drug Administration clearance to treat moderate to severe acute pain, a statement said on Thursday. The wholesale acquisition cost for the twice-daily medicine is set at US$15.50 per 50 milligram tablet, Vertex said.
Each year, about 125 million opioid prescriptions are written for Americans with pain caused by broken bones, burns, surgeries, and other injuries and procedures. More than half a million US deaths were linked to overdoses of the addictive drugs from 1999 to 2019, official figures show, with more than 70,000 in the year through June last year alone.
Photo:AP
While some fatalities involved use of illicit drugs, many people begin taking them after they lost access to prescribed opioids, leading doctors and health officials to look for other options.
Vertex’s drug has been hailed as a scientific breakthrough, because it allays pain without entering the brain, minimizing the risk of addiction and dependence that can lead patients to ramp up doses to dangerous levels. It is a key to Vertex’s strategy of diversifying beyond its core business centered on cystic fibrosis treatments.
While some analysts predict the painkiller would become a multibillion-dollar product for a company needing a growth driver, questions remain about its price and commercial potential. Health insurers and hospitals might continue steering patients to opioids, which — while dangerous — are cheap and effective.
Vertex has been pressing Congress to create policies that would help its product succeed. For example, the No Pain Act, which provides extra Medicare reimbursement to hospitals that prescribe alternatives to opioids, went into effect this year.
The company plans to focus on selling its drug to the about 2,000 US hospitals that see about two-thirds of patients in acute pain, chief operating officer Stuart Arbuckle said.
Boston-based Vertex, the maker of cystic fibrosis treatments like the blockbuster Trikafta, has worked for more than two decades to develop a nonaddictive pain drug. Journavx, also called suzetrigine, blocks a structure in the nerve cells that send pain signals to the brain.
In late-stage studies of patients with acute pain after surgery, Vertex’s drug worked better than a placebo, but failed to reduce pain faster than a combination of acetaminophen, better known as Tylenol, and an opioid. That could present a challenge for Vertex, as new drugs typically must outperform what is already on the market to gain traction.
Vertex is studying the same pill to treat chronic pain lasting at least three months, which affects about 50 million Americans. The company encountered a setback in December when a mid-stage trial showed the drug failed to work better than a placebo in lower back pain, causing the shares to plunge.
A deluge of disinformation about a virus called hMPV is stoking anti-China sentiment across Asia and spurring unfounded concerns of renewed lockdowns, despite experts dismissing comparisons with the COVID-19 pandemic five years ago. Agence France-Presse’s fact-checkers have debunked a slew of social media posts about the usually non-fatal respiratory disease human metapneumovirus after cases rose in China. Many of these posts claimed that people were dying and that a national emergency had been declared. Garnering tens of thousands of views, some posts recycled old footage from China’s draconian lockdowns during the COVID-19 pandemic, which originated in the country in late
French police on Monday arrested a man in his 20s on suspicion of murder after an 11-year-old girl was found dead in a wood south of Paris over the weekend in a killing that sparked shock and a massive search for clues. The girl, named as Louise, was found stabbed to death in the Essonne region south of Paris in the night of Friday to Saturday, police said. She had been missing since leaving school on Friday afternoon and was found just a few hundred meters from her school. A police source, who asked not to be named, said that she had been
VIOLENCE: The teacher had depression and took a leave of absence, but returned to the school last year, South Korean media reported A teacher stabbed an eight-year-old student to death at an elementary school in South Korea on Monday, local media reported, citing authorities. The teacher, a woman in her 40s, confessed to the crime after police officers found her and the young girl with stab wounds at the elementary school in the central city of Daejeon on Monday evening, the Yonhap news agency reported. The girl was brought to hospital “in an unconscious state, but she later died,” the report read. The teacher had stab wounds on her neck and arm, which officials determined might have been self-inflicted, the news agency
ISSUE: Some foreigners seek women to give birth to their children in Cambodia, and the 13 women were charged with contravening a law banning commercial surrogacy Philippine President Ferdinand Marcos Jr yesterday thanked Cambodian King Norodom Sihamoni for granting a royal pardon last year to 13 Filipino women who were convicted of illegally serving as surrogate mothers in the Southeast Asian kingdom. Marcos expressed his gratitude in a meeting with Cambodian Prime Minister Hun Manet, who was visiting Manila for talks on expanding trade, agricultural, tourism, cultural and security relations. The Philippines and Cambodia belong to the 10-nation ASEAN, a regional bloc that promotes economic integration but is divided on other issues, including countries whose security alignments is with the US or China. Marcos has strengthened